NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers provide details of new studies and findings in the area of breast cancer



February 23rd, 2006

New findings from the United Kingdom, Canada and Israel describe advances in breast cancer.

Study 1: 3'-Deoxy-3'-[F-18]fluorothymidine ([F-18]FLT)-positron emission tomography could be used to quantify cellular proliferation in breast cancer.

According to recent research from England, "There is an unmet need to develop imaging methods for the early and objective assessment of breast tumors to therapy. [F-18]FLT-positron emission tomography represents a new approach to imaging thymidine kinase activity, and hence, cellular proliferation. We compare graphical, spectral, and semiquantitative analytic methodologies for quantifying [F-18]FLT kinetics in...


Source: Women's Health Weekly (2006-02-23)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login